SEO URLwww.firestrike.ai/deals/purna-pharmaceuticals-ampersand-capital-acquisition-2026
acquisitionAnnounced · Feb 13, 2026PharmaceuticalSource · CredibleArticle · Factual
Ampersand Capital acquires Purna Pharmaceuticals
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Purna Pharmaceuticals
Puurs, Flanders
Acquirer
Ampersand Capital
Full Acquisition
Status
Completed
Ampersand Capital agreed to acquire Purna Pharmaceuticals. Reported deal value: Undisclosed. Status: Completed. Sector: Pharmaceutical. Target headquarters context: Puurs, Flanders, Belgium.
This page summarizes publicly available information about the transaction as of 2026-02-13. Figures and status may change as filings and press coverage update.
Copy and send link X Ampersand Capital Partners has acquired Purna Pharmaceuticals , a Belgium -based provider of development and manufacturing services for liquid and semi-solid dosage forms in the pharmaceutical sector
Deal timeline
Announced
Feb 13, 2026 · pharmaceutical-business-review.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceutical. Figures and status may change as sources update.
Sources: pharmaceutical-business-review.com · Primary article · FireStrike proprietary index